Identify technical limitations of standard linear accelerators in delivering ablative radiation dose for pancreas cancer. |
|
|
|
|
|
Describe the advanced capabilities of MR-linacs that enable safe ablation of pancreas cancer. |
|
|
|
|
|
Recognize expected outcomes after standard versus ablative radiation therapy doses for locally advanced pancreas cancer. |
|
|
|
|
|